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Abstract 
 
 
Background 
Severe traumatic brain injury (TBI) is a leading cause of mortality in children but the accurate 
prediction of outcomes at the point of admission remains very challenging. Admission laboratory results 
are a promising potential source of prognostic data but have not been widely explored in paediatric 
cohorts. Here in, we use machine-learning methods to analyse fourteen different serum parameters 
together and develop a prognostic model to predict 6-month outcomes in children with severe TBI.  
 
Methods 
A retrospective review of patients admitted to Cambridge University Hospital’s Paediatric Intensive 
Care Unit between 2009 and 2013 with a TBI. The data for fourteen admission serum parameters were 
recorded. Logistic regression and a Support Vector Machine (SVM) were trained with this data against 
dichotimised outcomes from the recorded 6-month Glasgow Outcome Scale. 
 
Results 
94 patients were identified. Admission levels of lactate, H+, and glucose were identified as being the 
most informative of six-month outcomes. Four different models were produced. The SVM using just the 
three most informative parameters was the best able to predict favourable outcomes at 6-months 
(sensitivity=80%, specificity=99%). 
 
 
Conclusions 
Our results demonstrate the potential for highly accurate outcome prediction after severe paediatric TBI 
using admission laboratory data. 
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Introduction 
 
Traumatic brain injury (TBI) remains a worldwide public health concern, carrying a significant burden 
of mortality and morbidity. TBI is a particular burden in the paediatric population, where it is estimated 
to be the leading cause of death in children over the age of 1(1,2).  
 
An accurate prognostic model in the context of TBI is valuable for both clinical and research purposes. 
Firstly, it aids clinical decision-making about a patient’s monitoring requirements and the necessity of 
surgical interventions. The extent of uncertainty in making these decisions has been recently highlighted 
by the results of the BEST-TRIP randomised-control trial (RCT), which has challenged the wisdom of 
implementing invasive monitoring for all severe TBI patients, and suggests that much better 
stratification of patients with this presentation may be required(3). Prognostic models can also be used 
to inform and direct research about the disease process and the risk factors for progression of secondary 
injury after TBI.   
 
A number of models using radiological and clinical parameters, such as initial CT scan and Glasgow 
Coma Score, to predict outcomes have been explored and validated in large adult cohorts but the 
evidence for the validity of these models in children is less compelling(4,5). Admission laboratory 
variables have also been explored in adult studies for prognostication, including a study on patients 
from the large IMPACT database(6). However, again, studies of these markers for paediatric cohorts are 
scant. This is despite the fact that children are known to differ in their pathophysiology after TBI and 
can generally expect better outcomes compared with similar injury in adults , necessitating specific 
paediatric evidence(7).  
 
Admission variables are a particularly useful potential source of prognostication: they are easily and 
routinely available (even in low- and middle-income countries [LMICs], where CT scans may not be), 
they may provide a possible avenue of clinical intervention (since many of the variables can be 
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corrected), and deranged values that are highly predictive may inform research efforts into the 
pathophysiology underlying brain injuries, which are currently poorly understood.  
 
Previous studies examining these variables (including a small number of paediatric studies) have 
focused on linear and, occasionally, non-linear models for single variables. However, given the 
numerous laboratory variables available and the possibility for interdependence and cross-correlation, 
using machine-learning methods to analyse all variables together in various permutations may help to 
provide the most robust interrogation of the data.  
 
In this context, we conducted this study to identify which, if any, admission laboratory variables are 
correlated to outcomes after TBI in children and to explore prediction of outcomes, using both 
univariate analysis and supervised learning methods. 
 
 
Methods 
Patient selection and data collection 
The clinical records of patients admitted to Cambridge University Hospital’s (CUH) Paediatric 
Intensive Care Unit (PICU) between January 2009 and December 2013 were retrospectively reviewed.  
Patients aged 16 and under, who had sustained a severe traumatic brain injury, were included for 
review. All patients received full active management of their TBI according to international guidelines, 
with a tiered treatment protocol based on positioning, sedation, muscle paralysis, moderate 
hyperventilation, ventriculostomy, osmotic agents, and induced hypothermia, aimed at maintaining 
intracranial pressure below 20mmHg(8,9). Inclusion criteria for the study were as follows: 1) confirmed 
TBI, using CT or MRI; 2) severe injury necessitating continued admission in PICU after day 1 post-
injury, due to continued requirement for sedation and/or close neurological monitoring; and 3) patients 
requiring invasive monitoring of intracranial pressure or arterial blood pressure.  
©    2019 Macmillan Publishers Limited, part of Springer Nature.
The electronic clinical records were examined for the data of laboratory blood tests taken in the 
Emergency Department on admission. Data for fourteen serum parameters were recorded, namely: 
glucose, haemoglobin (Hb), albumin, C-reactive protein (CRP), sodium, urea, magnesium, lactate, 
venous pH, white cell count (total), neutrophil count, haematocrit, prothrombin time (PT), activated 
partial thromboplastin time (APTT).  
 
All patients had been followed up at 6-months and the Glasgow Outcome Scale (GOS) [dead = GOS 1, 
vegetative state = GOS 2, severe disability = GOS 3, moderate disability = GOS 4, good recovery = 
GOS 5] was assessed 6-months after initial presentation in clinic and recorded in the electronic clinical 
records. The assessments were made based on age-appropriate markers for neurological function and 
activities of daily living. 
 
Statistical methods  
The GOS for each patient was dichotomised as favourable (GOS 4-5) versus unfavourable (GOS 1-3). 
Two machine-learning models were trained using this data, namely, linear regression and Support 
Vector Machine (SVM). The models were evaluated using five-fold cross-validation by averaging the 
relevant metrics across the folds. This cross-validated metric more accurately reflects the expected 
performance of our models for new test data that may be different from any previously observed 
training data. In the case of SVM models, the model parameters are optimised to maximise this cross-
validated metric, which prevents our selected models from over-fitting to the training data and 
consequently ensures our predictions generalise to new test data. Statistical analysis was carried out in 
Python, using the Scikit-learn and minepy libraries, and R. P-values were calculated using the two-tailed 
Mann-Whitney U-test. Plots were produced using the matplotlib Python library and the ggplot2 R 
library. 
Inspection of variables 
The Mutual Information (MI) between the blood result variables and the bipartite outcome was 
examined, along with the Correlation Coefficient (CC) of the same relationship. Higher MI between a 
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variable and the outcome indicates, broadly speaking, that the variable is more informative of the 
outcome. MI was measured using the Maximal Information Coefficient (MIC). MIC lies in the range [0, 
1], where 0 implies that the variable is uninformative of the outcome, and 1 represents a noise-free 
relationship between the variable and the outcome wherein the relationship may be of any form, linear 
or non-linear. The CC on the other hand is only an indication of the linear relationship between the 
variables and the outcome, and we examine the absolute value of the CC such that it falls in the same 
range of [0, 1] as the MIC, with similar interpretation. Higher absolute CC implies higher MIC but a 
highly informative variable, which will have a high MIC, may have a low absolute CC if it has a highly 
non-linear relationship with the outcome.  
Logistic regression 
A logistic regression model was trained and then evaluated by constructing Receiver-Operating 
Characteristic (ROC) curves of blood parameters against bipartite outcomes for each fold during the 
five-fold cross-validation to then produce an averaged ROC curve. The area-under-the-curve (AUC) 
was then calculated, with AUC>0.8 generally considered to indicate good performance. Youlden’s J-
statistic was used to calculate the optimal decision threshold, balancing sensitivity and specificity for 
predicting good outcomes.  
Support Vector Machine 
SVMs are supervised learning classifiers with state-of-the-art prediction performance. When used with 
the Radial Basis Function (RBF) kernel, they are capable of learning complex non-linear relationships 
between the variables and the classes. SVM based models using RBF kernels were developed in this 
work for predicting the bipartite outcome from serum result variables. The models have two parameters 
that need tuning for optimum performance: �, which acts as the regularisation parameter, and, �, which 
decides the degree of influence of a single training example. The models were evaluated, again using the 
J-statistic, across a range of both parameters, producing a grid of evaluation results. Each evaluation 
was by five-fold cross validation to penalise parameters that produce over-fitting models. This grid of 
results is presented as a heat-map and the highest performing parameter combinations are selected for 
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the final models.  
 
 
Results 
Demographics 
94 patients with a mean age of 7.3 years were admitted to CUH PICU in this period with a severe TBI. 
All patients had data for the fourteen variables of interest recorded. The Marshall scores ranged from 1 
to 5, with a mode of 2. The cohort’s demographic and laboratory data are summarised in Table 1.  
 
Inspection of variables  
A graphical plot of all the variables was produced, with the MIC on one axis and the absolute CC on 
another. Three outstanding variables were identified by visual inspection of the plot. These three 
variables are lactate, H+ (venous), and glucose, and they appear in the top-right quadrant, thereby being 
the most informative as well as most linearly correlated with the outcome (figure 1).  
Linear model  
Two logistic regression models were trained: a focused model that ignores all blood test variables in the 
data except the three most informative ones (i.e. lactate, H+ and glucose) and another that considers all 
the variables. Both models were evaluated with five-fold cross validation and a decision boundary was 
chosen to maximise the J-statistic.  
The focused model (figure 2a) predicted favourable outcomes with an AUC=0.83 (sensitivity=71%, 
specificity=99%). The AUC for the other model (figure 2b) in predicting favourable outcomes was 0.90 
(sensitivity=75%, specificity=99%).  
SVM model  
Two models were developed; one model considers all the variables, the other considers only the three 
most informative variables (as previously identified above).  
©    2019 Macmillan Publishers Limited, part of Springer Nature.
For the three-variable model, the optimal parameters discovered through the grid search (figure 3a) 
produces a model with sensitivity=80% and specificity=99%. For the model that considers all variables, 
optimised parameters through the grid search (figure 3b) produces a model with sensitivity=63% and 
specificity=100%.  
The performance of the four different models is summarised in Table 2.  
 
 
Discussion 
In this study, we identify admission levels of lactate, H+, and glucose as being the most informative of 
six-month outcomes after severe paediatric TBI. Using this information, we have constructed two types 
of model, three-variable and all-variable models, using both logistic regression and SVM analysis to 
predict outcomes. Of these, the three-variable SVM model was the most accurate in predicting 
favourable outcomes at six-months (sensitivity=80%). However, it is notable that all four models were 
highly specific (specificity>90% in all cases) i.e. reliable in correctly identifying those with 
unfavourable outcomes.   
 
High admission levels of lactate and glucose, as well as low admission pH, have been previously 
identified in adult studies as correlating with poor outcomes(10–12). Far fewer studies have been 
conducted in children but isolated hyperglycaemia has been previously identified in paediatric cohorts 
as predictive of poor outcomes(13,14)
,
(15). However, the therapeutic implications of these findings 
remain unclear for both adults and children; the most recent international guidelines for managing 
paediatric TBI found insufficient evidence to recommend intensive glycaemic control and concludes 
that further research is warranted – findings that are also supported by a recent meta-analysis of ten 
adult RCTs (n=1066)(16,17).  
 
Further work is also necessary to elucidate the nature of the relationship between glycaemia and 
outcomes as well as to determine whether there is any causal effect underlying the outcome associations 
and derangements of these three of these metabolic markers. Indeed, caution is advised before drawing 
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any mechanistic conclusions from these correlations; as one example, recent evidence suggests that the 
injured brain up-regulates lactate metabolism and that a certain degree of extracellular lactate may even 
be therapeutic after TBI(18,19)
,
(20).  
 
The reliability of our models demonstrates the potential for outcome stratification of paediatric TBI 
patients based on the point-of-admission blood results. This may prove particularly useful given the 
heterogeneity in outcomes for children compared to adults and would inform both treating clinicians as 
well as aid enrolment and classification decisions for clinical trials(21). Our model performs favourably 
compared to existing point-of-admission predictive models in adult TBI patients, with one recent large 
adult study (n=1089) achieving a sensitivity of 72% in predicting favourable outcomes(22–24). 
Moreover, these models have often included radiological markers from the initial CT scan. A major 
advantage of our model using only routine laboratory parameters is the accessibility it affords to 
clinicians in LMICs, where both CT scanners and radiological expertise may be less readily available. 
This is particularly important given the global burden of TBI, which is estimated to be three times more 
commonly encountered in LMIC healthcare systems compared with high-income countries (HIC)(25). 
We envisage that a fully validated model based on laboratory parameters would thus be of use not only 
in prognostication but also in evaluating the quality of TBI care provision in a healthcare system, as 
compared to the outcomes achieved in a cohort receiving the best standard of care in a HIC.  
 
More broadly, we have successfully demonstrated a three-part methodology to assess the predictive 
value of laboratory blood results for a clinical outcome, viz. (i) inspection of variables for the most 
informative variables, followed by (ii) logistic regression and, (iii) SVM analysis. In this way, both 
linear and complex, interacting, non-linear relationships in a dataset can be discovered. SVM analysis is 
a state-of-the-art machine-learning algorithm but it has not yet been widely used in clinical research. 
However, this is likely to be a developing field, with SVMs being increasingly recognised as a powerful 
algorithm that is well suited to detecting subtle patterns in ‘noisy’ biological data and a number of 
proof-of-principle studies have been conducted on large clinical datasets(26,27).   
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Our study was a single-centre review, including only patients admitted to intensive care and as such is 
limited by a modest sample size. This model must be evaluated on an external database and further 
work will be required to validate it as a clinical tool; in its current format, it should not be interpreted 
beyond being a proof-of-principle machine-learning model for serum variables in the context of 
paediatric TBI. Moreover, in this study we sought to demonstrate the isolated prognostic value of 
routine serum variables, however, given the statistical significance of admission Glasgow Coma Score 
and Marshall Score highlighted in our data (Table 1), we would envisage a final, comprehensive clinical 
tool to also integrate these physiological and imaging parameters. With a larger sample size, it would be 
valuable also to re-evaluate the model with stratified age-ranges, given the known and suggested 
differences in pathology after TBI between neonates, infants, and older children(7).  We highlight that 
early infection and other concurrent injuries are potential confounders that we did not attempt to exclude 
in this analysis, in order to arrive at a model that is applicable to real-world cohorts. However, this 
should be taken into account when attempting to draw any mechanistic conclusions about the 
pathophysiology of TBI based on these results.  
 
Conclusion 
Prognostication in the context of paediatric TBI is currently very difficult and the development of a 
reliable predictive model based on point-of-admission data would be of considerable value. We 
demonstrate a supervised learning method to assess the relationship between fourteen admission 
laboratory variables and outcomes after TBI in children and have developed a proof-of-principle 
prognostic model using this method.  
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Figures  
 
 
 
Figure 1 Maximal information coefficient (MIC) and absolute correlation coefficient (CC) between 
blood result variables and bipartite outcome. Venous concentrations of lactate, H+, and glucose are the 
most informative variables with outcome.  
 
 
 
 
Figure 2 ROC curves for logistic regression of: 
 
a) The three most informative parameters. Sensitivity=71%, specificity=99% 
 
 
 
 
 
b) All parameters. Sensitivity=75%, specificity=99% 
 
 
 
 
 
Figure 3 Heatmaps of the SVM parameter search. The SVM has two parameters, C (regularisation 
constant) and � (decides the degree of influence for any single training example). The performance of 
the SVM model depends entirely on these parameters. There is no analytical method to deduce the 
optimal parameters and, as such, they must be chosen by testing a variety of combinations. This varie ty 
of combinations is produced on a grid-search so that all possible combinations of C and �, within a set 
range, are tested. Each point on the heatmap is a unique combination of C and �.  
 
 
(a) Three most informative parameters. Sensitivity=80%, specificity=99% 
 
 
 
(b) All parameters. Sensitivity=63%, specificity=100% 
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Variables Favourable  Unfavourable p-value 
No. patients [%] 81 [86] 13 [14] NA 
Mean age ± SD (years) 7.3 ± 5.0 7.9 ± 5.4 0.67 
Males [%] 47 [58] 8 [62] 0.82 
Median admission GCS score [range] 13 [3-15] 3 [3-10] 0.0000021 
Median motor score [range] 6 [1-6] 1 [1-4] 0.0000012 
Median Marshall score [range] 1 [1-6] 3 [3-5] 0.022 
Mean glucose ± SD (mmol/L) 7.0 ± 1.9 10.4 ± 4.0 0.0045 
Mean haemoglobin (g/dL) 10.7 ± 1.8 11.3 ± 3.2 0.49 
Mean albumin (g/L) 34.7 ± 4.7 30.0 ± 7.7 0.051 
Mean C-reactive protein (mg/L) 16.9 ± 23.7 50.2 ± 43.6 0.010 
Mean sodium (mmol/L) 139.7 ± 3.3 143.7 ± 7.1 0.024 
Mean urea (mmol/L) 4.4  ± 1.2 4.7 ± 1.4 0.60 
Mean magnesium (mmol/L) 0.79 ± 0.1 0.8 ± 0.1 0.81 
Mean lactate (mmol/L) 1.5 ± 0.98 8.2 ± 4.1 0.00000088 
H+ (nmol/L) 39.7 ± 6.1 57.3 ± 10.1 0.0000029 
Total white cell count (x109/L) 13.2 ± 5.7 12.6 ± 4.6 0.99 
Neutrophil count (x109/L) 10.2 ± 5.3 9.8 ± 4.2 0.89 
Haematocrit (L/L) 0.31 ± 0.05 0.29 ± 0.09 0.36 
PT (seconds) 12.9 ± 1.4 17.5 ± 11.3 0.013 
APTT (seconds) 27.8 ± 3.6 33.1 ± 9.5 0.030 
 
 
Table 1 Summary of the cohort’s demographic and laboratory data, presented for patients split as 
favourable vs unfavourable outcomes.  
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 Sensitivity Specificity J-statistic AUC 
Linear model, all 
variables 
0.75 0.99 0.7 0.9 
Linear model, 
three variables 
0.71 0.99 0.74 0.83 
SVM, all 
variables 
0.63 1 0.79 N/A 
SVM, three 
variables 
0.8 0.99 0.63 N/A 
 
 
Table 2 A summary of the four models presented 
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